Mersana Therapeutics buy JPMorgan Chase & Co.
Start price
16.03.23
/
50%
€4.32
Target price
16.03.24
€9.45
Performance (%)
3.36%
End price
17.03.24
€4.47
Summary
This prediction ended on 17.03.24 with a price of €4.47. With a performance of 3.36%, the BUY prediction by JPMorgan_Chase___Co_ for Mersana Therapeutics closed with a slight gain. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mersana Therapeutics | 2.038% | 2.038% | -29.734% |
| iShares Core DAX® | 1.080% | -2.131% | 14.264% |
| iShares Nasdaq 100 | 0.362% | 7.059% | 35.383% |
| iShares Nikkei 225® | -1.155% | -0.483% | 8.258% |
| iShares S&P 500 | 0.806% | 5.037% | 29.635% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $10.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat
In the thread Trading Mersana Therapeutics
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten